Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by lscfaon May 19, 2022 10:03pm
132 Views
Post# 34697179

RE:Run-Rate $180M

RE:Run-Rate $180M

mgmt can't be bothered to present current no.s. They stick to the damn financial statement dates. Run rate is at $135 + $7.5 = $143 mil and there is a $14 mil LOI o/s from Nov 2021.  


Justin Keywood

Good morning. Thanks for taking the call. First, just a clarification on the run rate mentioned earlier of 135. Does that include Goodnight Medical?

Greg Crawford

No.

Justin Keywood

Okay. So a little higher than 135, but still below the reiterated guidance of $180 million to $190 million. So that implies that there's a lot of M&A opportunity in the back half of the year. How confident are you in executing on that M&A? And what are some of the factors that could defer some of those processes into the next year?

<< Previous
Bullboard Posts
Next >>